Similarly, since reduced Ubqn levels result in a modest decrease in APP levels, whereas expression of both human wildtype and the AD variant of UBQLN1 leads to adult onset, age-dependent eye degeneration in Drosophila[47], UBQLN1 may also be considered as a possible drug target for AD. Here, APP is linked to Alzheimer disease.